Material Event (Form 8-K)

Other Events.

Pursuant to the current amended and restated certificate of incorporation of Moleculin Biotech, Inc. (the 'Company'), the affirmative vote of the holders of at least two-thirds of the voting power of all then outstanding shares of capital stock of the Company entitled to vote generally in the election of directors, voting together as a single class, is required to amend, alter or repeal certain provisions of the certificate of incorporation.

On May 13, 2021, the board of directors of Moleculin Biotech, Inc. (the 'Company') approved amendments to the Company's certificate of incorporation to provide that amendments to the certificate of incorporation shall only require the approval of a majority of the voting power of all then outstanding shares of capital stock of the Company entitled to vote generally in the election of directors, voting together as a single class, at a duly called meeting of the Company's stockholders. The board of directors has directed that the amendments to the certificate of incorporation be submitted for approval by the Company's shareholders at the Company's 2022 Annual Meeting of Shareholders and will recommend that the Company's shareholders approve the amendments to the certificate of incorporation at that meeting.

Public link

Please use the above public link if you want to share this noodl on another website.